Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Centre for Health Protection today said it is investigating two additional imported COVID-19 cases.
They arrived in Hong Kong from the US and Japan.
A total of 36 cases were reported in Hong Kong in the past 14 days, one of which is a local case with unknown infection sources while the rest are imported.
The centre also reminded specified persons in relation to the Sea View Mansion in Sai Ying Pun to undergo compulsory testing in accordance with the compulsory testing notice tomorrow.
For information and health advice on COVID-19, visit the Government’s dedicated webpage.
http://dlvr.it/S5GQDQ
http://dlvr.it/S5GQDQ